Clinical Trial Update: Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis [Phase 1]

View source ↗

Summary

Betta Pharmaceuticals completed a Phase 1 trial evaluating icotinib hydrochloride cream for mild to moderate psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Icotinib hydrochloride cream (icotinib hydrochloride)

Snippet

Sponsor: Betta Pharmaceuticals Co., Ltd. | Conditions: Psoriasis | Phase 1 | Status: COMPLETED